Last reviewed · How we verify

NCT03789747

Acute Kidney Injury After Craniotomy

Completed Last updated 11 February 2025
What this trial tests

trial testing As a observational study, there is no intervention. in Epidemiology in 143 participants. Completed in 30 April 2020.

Timeline
1 January 2017
Primary endpoint
31 December 2018
30 April 2020

Quick facts

Lead sponsorBeijing Tiantan Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment143
Start date1 January 2017
Primary completion31 December 2018
Estimated completion30 April 2020
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Beijing Tiantan Hospital

Who can join

18 and older, any sex, with Epidemiology or Acute Kidney Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to investigate the incidence, risk factors and prognosis of acute kidney injury (AKI) in critically ill patients after craniotomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Epidemiology

Currently open trials in the same condition.

Other Beijing Tiantan Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03789747.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing